213 related articles for article (PubMed ID: 20712585)
1. Metformin and energy metabolism in breast cancer: from insulin physiology to tumour-initiating stem cells.
Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Martin-Castillo B; Menendez JA
Curr Mol Med; 2010 Oct; 10(7):674-91. PubMed ID: 20712585
[TBL] [Abstract][Full Text] [Related]
2. Metformin: from mechanisms of action to therapies.
Foretz M; Guigas B; Bertrand L; Pollak M; Viollet B
Cell Metab; 2014 Dec; 20(6):953-66. PubMed ID: 25456737
[TBL] [Abstract][Full Text] [Related]
3. Metformin is synthetically lethal with glucose withdrawal in cancer cells.
Menendez JA; Oliveras-Ferraros C; Cufí S; Corominas-Faja B; Joven J; Martin-Castillo B; Vazquez-Martin A
Cell Cycle; 2012 Aug; 11(15):2782-92. PubMed ID: 22809961
[TBL] [Abstract][Full Text] [Related]
4. Metformin: taking away the candy for cancer?
Jalving M; Gietema JA; Lefrandt JD; de Jong S; Reyners AK; Gans RO; de Vries EG
Eur J Cancer; 2010 Sep; 46(13):2369-80. PubMed ID: 20656475
[TBL] [Abstract][Full Text] [Related]
5. Metformin and Breast Cancer: Molecular Targets.
Faria J; Negalha G; Azevedo A; Martel F
J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
[TBL] [Abstract][Full Text] [Related]
6. Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin.
Wysocki PJ; Wierusz-Wysocka B
Expert Rev Mol Diagn; 2010 May; 10(4):509-19. PubMed ID: 20465505
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial targets of metformin-Are they physiologically relevant?
Pecinová A; Brázdová A; Drahota Z; Houštěk J; Mráček T
Biofactors; 2019 Sep; 45(5):703-711. PubMed ID: 31343786
[TBL] [Abstract][Full Text] [Related]
8. Cancer research. Cancer prevention with a diabetes pill?
Taubes G
Science; 2012 Jan; 335(6064):29. PubMed ID: 22223788
[No Abstract] [Full Text] [Related]
9. A review for clinicians: Prostate cancer and the antineoplastic properties of metformin.
Hankinson SJ; Fam M; Patel NN
Urol Oncol; 2017 Jan; 35(1):21-29. PubMed ID: 27836248
[TBL] [Abstract][Full Text] [Related]
10. Metformin: "Old warrior for a new battle".
Jain A
Indian J Cancer; 2010; 47(4):471-2. PubMed ID: 21131766
[No Abstract] [Full Text] [Related]
11. Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy.
Vona-Davis L; Rose DP
Curr Diabetes Rev; 2012 Mar; 8(2):116-30. PubMed ID: 22268396
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial metabolism and type-2 diabetes: a specific target of metformin.
Leverve XM; Guigas B; Detaille D; Batandier C; Koceir EA; Chauvin C; Fontaine E; Wiernsperger NF
Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S88-94. PubMed ID: 14502105
[TBL] [Abstract][Full Text] [Related]
13. Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
Markowicz-Piasecka M; Sikora J; Szydłowska A; Skupień A; Mikiciuk-Olasik E; Huttunen KM
Pharm Res; 2017 Dec; 34(12):2614-2627. PubMed ID: 28589443
[TBL] [Abstract][Full Text] [Related]
14. Metformin and neoplasia: implications and indications.
Aljada A; Mousa SA
Pharmacol Ther; 2012 Jan; 133(1):108-15. PubMed ID: 21924289
[TBL] [Abstract][Full Text] [Related]
15. Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study.
Dowling RJ; Niraula S; Chang MC; Done SJ; Ennis M; McCready DR; Leong WL; Escallon JM; Reedijk M; Goodwin PJ; Stambolic V
Breast Cancer Res; 2015 Mar; 17(1):32. PubMed ID: 25849721
[TBL] [Abstract][Full Text] [Related]
16. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
An H; He L
J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
[TBL] [Abstract][Full Text] [Related]
17. Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications.
Bashraheel SS; Kheraldine H; Khalaf S; Moustafa AA
Biomed Pharmacother; 2023 Jun; 162():114676. PubMed ID: 37037091
[TBL] [Abstract][Full Text] [Related]
18. Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects.
Luna V; Casauban L; Sajan MP; Gomez-Daspet J; Powe JL; Miura A; Rivas J; Standaert ML; Farese RV
Diabetologia; 2006 Feb; 49(2):375-82. PubMed ID: 16395615
[TBL] [Abstract][Full Text] [Related]
19. Metabolic switching in the hypoglycemic and antitumor effects of metformin on high glucose induced HepG2 cells.
Lv Y; Tian N; Wang J; Yang M; Kong L
J Pharm Biomed Anal; 2018 Jul; 156():153-162. PubMed ID: 29705631
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective Effects of Metformin.
Driver C; Bamitale KDS; Kazi A; Olla M; Nyane NA; Owira PMO
J Cardiovasc Pharmacol; 2018 Aug; 72(2):121-127. PubMed ID: 29738369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
